Critical Therapeutics.

Privately held biopharmaceutical company focused on critical care medicine.

Launch date

2000

Market cap

Enterprise valuation

Lexington Kentucky (HQ)

Date	Investors	Amount	Round
Nov 2002	HealthCare Ventures MPM BioImpact	$10.0m	Series A
Oct 2003	HealthCare Ventures Johnson & Johnson Development Corporation MPM BioImpact MedImmune Ventures Advanced Technology Ventures Oxford Bioscience Partners	$56.0m	Series B
May 2008	Cornerstone Therapeutics	N/A	Acquisition
Total Funding		AUD102m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Critical Therapeutics.